Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline

Alzheimer's & Dementia - Tập 6 - Trang 456-464 - 2010
Karin Yurko-Mauro1, Deanna McCarthy1, Dror Rom2, Edward B. Nelson1, Alan S. Ryan1, Andrew Blackwell3, Norman Salem1, Mary Stedman4
1Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
2Prosoft Software, Inc, Wayne, PA, USA
3Cambridge Cognition Ltd, Cambridge United Kingdom
4Stedman Clinical Trials, Tampa, FL, USA

Tóm tắt

BackgroundDocosahexaenoic acid (DHA) plays an important role in neural function. Decreases in plasma DHA are associated with cognitive decline in healthy elderly adults and in patients with Alzheimer's disease. Higher DHA intake is inversely correlated with relative risk of Alzheimer's disease. The potential benefits of DHA supplementation in age‐related cognitive decline (ARCD) have not been fully examined.ObjectiveDetermine effects of DHA administration on improving cognitive functions in healthy older adults with ARCD.MethodsRandomized, double‐blind, placebo‐controlled, clinical study was conducted at 19 U.S. clinical sites. A total of 485 healthy subjects, aged ≥55 with Mini‐Mental State Examination >26 and a Logical Memory (Wechsler Memory Scale III) baseline score ≥1 standard deviation below younger adults, were randomly assigned to 900 mg/d of DHA orally or matching placebo for 24 weeks. The primary outcome was the CANTAB Paired Associate Learning (PAL), a visuospatial learning and episodic memory test.ResultsIntention‐to‐treat analysis demonstrated significantly fewer PAL six pattern errors with DHA versus placebo at 24 weeks (difference score, −1.63 ± 0.76 [−3.1, −0.14, 95% CI], P = .03). DHA supplementation was also associated with improved immediate and delayed Verbal Recognition Memory scores (P < .02), but not working memory or executive function tests. Plasma DHA levels doubled and correlated with improved PAL scores (P < .02) in the DHA group. DHA was well tolerated with no reported treatment‐related serious adverse events.ConclusionsTwenty‐four week supplementation with 900 mg/d DHA improved learning and memory function in ARCD and is a beneficial supplement that supports cognitive health with aging.Trial RegistrationClinicaltrials.gov, Identifier: NCT0027813.

Tài liệu tham khảo

Alzheimer's Association.Alzheimer's disease and maintaining brain and memory health national survey results 2004. Available athttp://www.alz.org/alzheimers_disease_publications_reports.asp. Accessed February 15 2005. 10.7326/0003-4819-148-6-200803180-00005 10.1093/ajcn/77.4.803 10.1093/ajcn/85.4.1103 10.1007/s11745-000-0646-3 10.1001/archneur.63.11.1545 Noel K., 2006, DHA and cognitive function in the elderly: a systematic review of the literature, Res Pract Alzheimer's Dis, 11, 381 10.1001/archneur.60.7.940 10.1212/01.WNL.0000103860.75218.A5 10.1016/S0163-7827(00)00017-5 10.1007/s11745-001-0805-6 10.1054/plef.2002.0408 10.1016/S0006-8993(00)02115-6 10.1093/gerona/63.11.1153 10.1523/JNEUROSCI.4225-04.2005 10.1523/JNEUROSCI.0055-07.2007 10.1212/01.wnl.0000324268.45138.86 10.1016/j.pnpbp.2008.05.015 10.1001/archneur.63.10.1402 10.1016/j.jalz.2008.07.003 Robbins T.W., 1994, Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers, Dementia, 5, 266 10.1017/S003329170200524X Cargin J.W., 2006, Mild memory impairment in healthy older adults is distinct from normal aging, Brain Cogn, 60, 146, 10.1016/j.bandc.2005.10.004 10.1002/ana.10105 10.1016/j.pnpbp.2007.01.011 American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders 10.1080/87565648609540348 BenisekD Bailey‐HallE OkenH MasayesvaS ArterburnL.Validation of a simple food frequency questionnaire as an indicator of long chain omega‐3 intake. In: Inform 2002; Abstracts of the 93rd Annual AOCS Meeting and Expo; 2002; Montreal Quebec Canada:S96. Arterburn L.M., 2006, Distribution, interconversion, and dose response of n‐3 fatty acids in humans, Am J Clin Nutr, 83, 10.1093/ajcn/83.6.1467S 10.1097/MJT.0b013e31817fe2be FDA.Agency Response Letter Gras Notification No. GRN000137; February 12 2004. 10.1080/13607860410001709665 10.1097/01.wad.0000213873.25053.2b 10.1016/0022-3956(75)90026-6 10.1016/0022-3956(82)90033-4 10.1007/s11745-007-3098-5 USDA.Nutrient intakes from food: mean amounts consumed per individual one day 2003‐2004.USDA Agricultural Research Service 2007. Available athttp://www.ars.usda.gov/ba/bhnrc/fsrg. Accessed December 17 2007 10.1161/CIRCULATIONAHA.108.191261 10.1017/S1355617702811067 10.1159/000074081 10.1159/000051269 10.1111/j.1365-2796.2006.01687.x 10.1161/01.HYP.34.2.253
Thông tin
Thông tin xuất bản

Alzheimer's & Dementia

Tập 6

456-464

Thông tin tác giả